Locations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · DeepTech
Size
11-50 employees
Stage
Series B
founded in
2019
Ankyra Therapeutics is a clinical-stage biotech company focused on developing anchored-drug conjugates to enhance anti-tumor responses while ensuring patient safety. Their innovative Anchored Immunotherapy platform aims to improve the therapeutic window of drugs by binding them to aluminum hydroxide, allowing for prolonged retention in tumors and minimizing systemic side effects. The company's lead product, ANK-101, is currently being evaluated in patients with advanced solid tumors after showing promising results in preclinical models. Ankyra's mission is to optimize the impact of their therapies to improve the lives of cancer patients, positioning them as a significant player in the oncology market.
Something looks off?On-site & Remote